Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.635 USD | -3.23% | -13.93% | -31.91% |
04:00pm | Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM | |
05-09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.91% | 559M | |
+10.89% | 115B | |
+12.45% | 106B | |
-4.27% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.56% | 17.56B | |
-40.50% | 17.32B | |
+6.30% | 14.03B | |
+31.68% | 12.13B |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- B. Riley Lowers Altimmune's Price Target to $21 from $27 After Revising Cost Capital Assumptions, Keeps Buy Rating